JADENU
JADENU
Approved
DIN Number
02452219
Drug Class
Human
Market Date
Mar 24, 2016
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02452219
AIG Number0151733004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AC03 DEFERASIROX
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification64:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DEFERASIROXActive
Strength: 90 MG
Monograph: DEFERASIROX